{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T17:07:22Z","timestamp":1754154442876,"version":"3.41.2"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,24]]},"DOI":"10.7759\/cureus.88651","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T09:54:21Z","timestamp":1753350861000},"source":"Crossref","is-referenced-by-count":0,"title":["Factor VIII Inhibitors in the Context of Renal Cell Carcinoma and Hemophilia A: A Tale of Two Causes"],"prefix":"10.7759","author":[{"given":"Rami","family":"Madani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Z","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Ayoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talal","family":"Al-Assil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Usman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.230771","article-title":"International recommendations on the diagnosis and treatment of acquired hemophilia A","volume":"105","author":"Tiede A","year":"2020","unstructured":"Tiede A, Collins P, Knoebl P, et al.. International recommendations on the diagnosis and treatment of acquired hemophilia A. Haematologica. 2020, 105:1791-801. 10.3324\/haematol.2019.230771","journal-title":"Haematologica"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1516437","article-title":"A randomized trial of Factor VIII and neutralizing antibodies in hemophilia A","volume":"374","author":"Peyvandi F","year":"2016","unstructured":"Peyvandi F, Mannucci PM, Garagiola I, et al.. A randomized trial of Factor VIII and neutralizing antibodies in hemophilia A. N Engl J Med. 2016, 374:2054-64. 10.1056\/NEJMoa1516437","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.12.004","article-title":"Incidence of inhibitor development in PUPs with severe haemophilia A in the CEE region between 2005 and 2015","volume":"198","author":"Blatn\u00fd J","year":"2021","unstructured":"Blatn\u00fd J, Kardos M, Miljic P, et al.. Incidence of inhibitor development in PUPs with severe haemophilia A in the CEE region between 2005 and 2015. Thromb Res. 2021, 198:196-203. 10.1016\/j.thromres.2020.12.004","journal-title":"Thromb Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2010.11.005","article-title":"Acquired hemophilia A: Diagnosis, aetiology, clinical spectrum and treatment options","volume":"10","author":"Shetty S","year":"2011","unstructured":"Shetty S, Bhave M, Ghosh K. Acquired hemophilia A: Diagnosis, aetiology, clinical spectrum and treatment options. Autoimmun Rev. 2011, 10:311-6. 10.1016\/j.autrev.2010.11.005","journal-title":"Autoimmun Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(12)70019-1","article-title":"Acquired hemophilia in malignancy","volume":"129 Suppl 1","author":"Reeves BN","year":"2012","unstructured":"Reeves BN, Key NS. Acquired hemophilia in malignancy. Thromb Res. 2012, 129 Suppl 1:S66-8. 10.1016\/S0049-3848(12)70019-1","journal-title":"Thromb Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13355","article-title":"Acquired haemophilia in cancer: A systematic and critical literature review","volume":"24","author":"Napolitano M","year":"2018","unstructured":"Napolitano M, Siragusa S, Mancuso S, Kessler CM. Acquired haemophilia in cancer: A systematic and critical literature review. Haemophilia. 2018, 24:43-56. 10.1111\/hae.13355","journal-title":"Haemophilia"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1160\/TH08-08-0543","article-title":"Elevation of B cell-activating factor belonging to the tumour necrosis factor [corrected] family (BAFF) in haemophilia A patients with inhibitor","volume":"101","author":"Takeda T","year":"2009","unstructured":"Takeda T, Sakurai Y, Tatsumi K, Kato J, Kasuda S, Yoshioka A, Shima M. Elevation of B cell-activating factor belonging to the tumour necrosis factor [corrected] family (BAFF) in haemophilia A patients with inhibitor. Thromb Haemost. 2009, 101:408-10.","journal-title":"Thromb Haemost"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/320674","article-title":"Acquired hemophilia A: A frequently overlooked autoimmune hemorrhagic disorder","volume":"2014","author":"Sakurai Y","year":"2014","unstructured":"Sakurai Y, Takeda T. Acquired hemophilia A: A frequently overlooked autoimmune hemorrhagic disorder. J Immunol Res. 2014, 2014:320674. 10.1155\/2014\/320674","journal-title":"J Immunol Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3233\/ACP-2011-0001","article-title":"Detection of the TNFSF members BAFF, APRIL, TWEAK and their receptors in normal kidney and renal cell carcinomas","volume":"34","author":"Pelekanou V","year":"2011","unstructured":"Pelekanou V, Notas G, Theodoropoulou K, et al.. Detection of the TNFSF members BAFF, APRIL, TWEAK and their receptors in normal kidney and renal cell carcinomas. Anal Cell Pathol (Amst). 2011, 34:49-60. 10.3233\/ACP-2011-0001","journal-title":"Anal Cell Pathol (Amst)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12065","article-title":"Dangerous liaisons: How the immune system deals with factor\u00a0VIII","volume":"11","author":"Wroblewska A","year":"2013","unstructured":"Wroblewska A, Reipert BM, Pratt KP, Voorberg J. Dangerous liaisons: How the immune system deals with factor\u00a0VIII. J Thromb Haemost. 2013, 11:47-55. 10.1111\/jth.12065","journal-title":"J Thromb Haemost"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1160\/TH14-09-0789","article-title":"Danger signal-dependent activation of human dendritic cells by plasma-derived factor VIII products","volume":"114","author":"Miller L","year":"2015","unstructured":"Miller L, Weissm\u00fcller S, Ringler E, Crauwels P, van Zandbergen G, Seitz R, Waibler Z. Danger signal-dependent activation of human dendritic cells by plasma-derived factor VIII products. Thromb Haemost. 2015, 114:268-76. 10.1160\/TH14-09-0789","journal-title":"Thromb Haemost"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-483263","article-title":"Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A","volume":"122","author":"Eckhardt CL","year":"2013","unstructured":"Eckhardt CL, van Velzen AS, Peters M, et al.. Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A. Blood. 2013, 122:1954-62. 10.1182\/blood-2013-02-483263","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2018.05.027","article-title":"Risk factors for inhibitor development in severe hemophilia a","volume":"168","author":"Garagiola I","year":"2018","unstructured":"Garagiola I, Palla R, Peyvandi F. Risk factors for inhibitor development in severe hemophilia a. Thromb Res. 2018, 168:20-7. 10.1016\/j.thromres.2018.05.027","journal-title":"Thromb Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/388672-factor-viii-inhibitors-in-the-context-of-renal-cell-carcinoma-and-hemophilia-a-a-tale-of-two-causes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T09:54:21Z","timestamp":1753350861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/388672-factor-viii-inhibitors-in-the-context-of-renal-cell-carcinoma-and-hemophilia-a-a-tale-of-two-causes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.88651","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,7,24]]}}}